Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
5.67
-0.24 (-4.06%)
Aug 15, 2025, 4:00 PM - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $6.26 million as of August 15, 2025. Its market cap has decreased by -74.32% in one year.
Market Cap
6.26M
Enterprise Value
-2.29M
1-Year Change
-74.32%
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $6.26M, a decrease of -95.17%. That is a compound annual growth rate of -55.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 6.52M | -39.35% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 633.17B |
| Johnson & Johnson | 426.64B |
| AbbVie | 364.48B |
| UnitedHealth Group | 277.66B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Abbott Laboratories | 229.29B |
| Novo Nordisk | 225.09B |